Género, biomedicina y el virus del papiloma humano en México. Algunas complejidades sociotécnicas en la política pública de vacunación

INTRODUCTION. The Human Papillomavirus (HPV) preventive vaccine emerged in 2000’s first decade as a biomedical alternative to decrease cervical cases rates, that represent one of the leading death causes among young women in Latin America and other countries that face inequalities. OBJECTIVE. To ana...

Full description

Bibliographic Details
Main Author: César Torres-Cruz
Format: Article
Language:Spanish
Published: Universitat de Barcelona 2023-05-01
Series:Musas
Subjects:
Online Access:https://revistes.ub.edu/index.php/MUSAS/article/view/42326/39564
_version_ 1797803468040175616
author César Torres-Cruz
author_facet César Torres-Cruz
author_sort César Torres-Cruz
collection DOAJ
description INTRODUCTION. The Human Papillomavirus (HPV) preventive vaccine emerged in 2000’s first decade as a biomedical alternative to decrease cervical cases rates, that represent one of the leading death causes among young women in Latin America and other countries that face inequalities. OBJECTIVE. To analyze the configuration of HPV vaccination public policy in Mexico, from the «stratified biomedicalization» of sexual risk. MATERIAL AND METHODS. A qualitative approach, that includes in-depth interviews with key actors in the configuration of the Mexican public policy HPV vaccination from a sociological interpretative focus was carried out. RESULTS. It is highlighted how there were embedded big pharma, scientific knowledge, governmental decisions as well as notions regarding gender and sexuality to immunize only 11-year-old girls. CONCLUSIONS. It is necessary to revise the necessity of including gender perspective to create an HPV vaccination public policy more inclusive.
first_indexed 2024-03-13T05:22:17Z
format Article
id doaj.art-726ce6333c294045b5f7307994a2427a
institution Directory Open Access Journal
issn 2385-7005
language Spanish
last_indexed 2024-03-13T05:22:17Z
publishDate 2023-05-01
publisher Universitat de Barcelona
record_format Article
series Musas
spelling doaj.art-726ce6333c294045b5f7307994a2427a2023-06-15T12:32:12ZspaUniversitat de BarcelonaMusas2385-70052023-05-01813960doi:10.1344/musas2023.vol8.num1.3Género, biomedicina y el virus del papiloma humano en México. Algunas complejidades sociotécnicas en la política pública de vacunación César Torres-Cruz0https://orcid.org/0000-0003-3752-1005Centro de Investigaciones y Estudios de Género de la Universidad Nacional Autónoma de México (CIEG-UNAM). (Ciudad de México, México) INTRODUCTION. The Human Papillomavirus (HPV) preventive vaccine emerged in 2000’s first decade as a biomedical alternative to decrease cervical cases rates, that represent one of the leading death causes among young women in Latin America and other countries that face inequalities. OBJECTIVE. To analyze the configuration of HPV vaccination public policy in Mexico, from the «stratified biomedicalization» of sexual risk. MATERIAL AND METHODS. A qualitative approach, that includes in-depth interviews with key actors in the configuration of the Mexican public policy HPV vaccination from a sociological interpretative focus was carried out. RESULTS. It is highlighted how there were embedded big pharma, scientific knowledge, governmental decisions as well as notions regarding gender and sexuality to immunize only 11-year-old girls. CONCLUSIONS. It is necessary to revise the necessity of including gender perspective to create an HPV vaccination public policy more inclusive.https://revistes.ub.edu/index.php/MUSAS/article/view/42326/39564hpv vaccinationcervical cancermexico
spellingShingle César Torres-Cruz
Género, biomedicina y el virus del papiloma humano en México. Algunas complejidades sociotécnicas en la política pública de vacunación
Musas
hpv vaccination
cervical cancer
mexico
title Género, biomedicina y el virus del papiloma humano en México. Algunas complejidades sociotécnicas en la política pública de vacunación
title_full Género, biomedicina y el virus del papiloma humano en México. Algunas complejidades sociotécnicas en la política pública de vacunación
title_fullStr Género, biomedicina y el virus del papiloma humano en México. Algunas complejidades sociotécnicas en la política pública de vacunación
title_full_unstemmed Género, biomedicina y el virus del papiloma humano en México. Algunas complejidades sociotécnicas en la política pública de vacunación
title_short Género, biomedicina y el virus del papiloma humano en México. Algunas complejidades sociotécnicas en la política pública de vacunación
title_sort genero biomedicina y el virus del papiloma humano en mexico algunas complejidades sociotecnicas en la politica publica de vacunacion
topic hpv vaccination
cervical cancer
mexico
url https://revistes.ub.edu/index.php/MUSAS/article/view/42326/39564
work_keys_str_mv AT cesartorrescruz generobiomedicinayelvirusdelpapilomahumanoenmexicoalgunascomplejidadessociotecnicasenlapoliticapublicadevacunacion